Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Combining culture and culture-independent methods reveals new microbial composition of halitosis patients' tongue biofilm.

Bernardi S, Karygianni L, Filippi A, Anderson AC, Zürcher A, Hellwig E, Vach K, Macchiarelli G, Al-Ahmad A.

Microbiologyopen. 2019 Nov 14:e958. doi: 10.1002/mbo3.958. [Epub ahead of print]

2.

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.

Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Aguilera AR, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, Spatola BN, Soros VB, Corbin J, Anderson AC, Effern M, Hölzel M, Robson SC, Johnston RL, Waddell N, Smith C, Bald T, Geetha N, Beers C, Teng MWL, Smyth MJ.

Cancer Discov. 2019 Dec;9(12):1754-1773. doi: 10.1158/2159-8290.CD-19-0541. Epub 2019 Nov 7.

PMID:
31699796
3.

TIM3 comes of age as an inhibitory receptor.

Wolf Y, Anderson AC, Kuchroo VK.

Nat Rev Immunol. 2019 Nov 1. doi: 10.1038/s41577-019-0224-6. [Epub ahead of print] Review.

PMID:
31676858
4.

New Clones on the Block.

Acharya N, Anderson AC.

Immunity. 2019 Oct 15;51(4):606-608. doi: 10.1016/j.immuni.2019.09.018.

PMID:
31618653
5.

Cryptosporidium Incidence and Surface Water Influence of Groundwater Supplying Public Water Systems in Minnesota, USA.

Stokdyk JP, Spencer SK, Walsh JF, de Lambert JR, Firnstahl AD, Anderson AC, Rezania LW, Borchardt MA.

Environ Sci Technol. 2019 Apr 2;53(7):3391-3398. doi: 10.1021/acs.est.8b05446. Epub 2019 Mar 21.

PMID:
30895775
6.

ACO Affiliated Hospitals Increase Implementation of Care Coordination Strategies.

Anderson AC, Chen J.

Med Care. 2019 Apr;57(4):300-304. doi: 10.1097/MLR.0000000000001080.

PMID:
30807454
7.

Structural and Functional Studies of Bacterial Enolase, a Potential Target against Gram-Negative Pathogens.

Krucinska J, Falcone E, Erlandsen H, Hazeen A, Lombardo MN, Estrada A, Robinson VL, Anderson AC, Wright DL.

Biochemistry. 2019 Mar 5;58(9):1188-1197. doi: 10.1021/acs.biochem.8b01298. Epub 2019 Feb 15.

PMID:
30714720
8.

Revolutionizing Cancer Immunology: The Power of Next-Generation Sequencing Technologies.

Singer M, Anderson AC.

Cancer Immunol Res. 2019 Feb;7(2):168-173. doi: 10.1158/2326-6066.CIR-18-0281. Review.

PMID:
30709909
9.

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.

Kurtulus S, Madi A, Escobar G, Klapholz M, Nyman J, Christian E, Pawlak M, Dionne D, Xia J, Rozenblatt-Rosen O, Kuchroo VK, Regev A, Anderson AC.

Immunity. 2019 Jan 15;50(1):181-194.e6. doi: 10.1016/j.immuni.2018.11.014. Epub 2019 Jan 8.

PMID:
30635236
10.

Mohs micrographic surgery overlying a pacemaker.

Lane JE, Anderson AC.

Cutis. 2018 Oct;102(4):E33-E34. No abstract available.

PMID:
30489567
11.

In-vivo shift of the microbiota in oral biofilm in response to frequent sucrose consumption.

Anderson AC, Rothballer M, Altenburger MJ, Woelber JP, Karygianni L, Lagkouvardos I, Hellwig E, Al-Ahmad A.

Sci Rep. 2018 Sep 21;8(1):14202. doi: 10.1038/s41598-018-32544-6.

12.

Exploring national trends of patient- and family-centered care among US children.

Anderson AC, Akre E, Chen J.

J Child Health Care. 2019 Jun;23(2):200-212. doi: 10.1177/1367493518786015. Epub 2018 Jul 17.

PMID:
30016885
13.

Induction and transcriptional regulation of the co-inhibitory gene module in T cells.

Chihara N, Madi A, Kondo T, Zhang H, Acharya N, Singer M, Nyman J, Marjanovic ND, Kowalczyk MS, Wang C, Kurtulus S, Law T, Etminan Y, Nevin J, Buckley CD, Burkett PR, Buenrostro JD, Rozenblatt-Rosen O, Anderson AC, Regev A, Kuchroo VK.

Nature. 2018 Jun;558(7710):454-459. doi: 10.1038/s41586-018-0206-z. Epub 2018 Jun 13.

14.
15.

Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.

Nakashima H, Nguyen T, Kasai K, Passaro C, Ito H, Goins WF, Shaikh I, Erdelyi R, Nishihara R, Nakano I, Reardon DA, Anderson AC, Kuchroo V, Chiocca EA.

Clin Cancer Res. 2018 Jun 1;24(11):2574-2584. doi: 10.1158/1078-0432.CCR-17-2954. Epub 2018 Mar 6.

16.

Promoting Health Equity And Eliminating Disparities Through Performance Measurement And Payment.

Anderson AC, O'Rourke E, Chin MH, Ponce NA, Bernheim SM, Burstin H.

Health Aff (Millwood). 2018 Mar;37(3):371-377. doi: 10.1377/hlthaff.2017.1301.

PMID:
29505363
17.

Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity.

Dixon KO, Schorer M, Nevin J, Etminan Y, Amoozgar Z, Kondo T, Kurtulus S, Kassam N, Sobel RA, Fukumura D, Jain RK, Anderson AC, Kuchroo VK, Joller N.

J Immunol. 2018 Apr 15;200(8):3000-3007. doi: 10.4049/jimmunol.1700407. Epub 2018 Mar 2.

18.

Shift of microbial composition of peri-implantitis-associated oral biofilm as revealed by 16S rRNA gene cloning.

Al-Ahmad A, Muzafferiy F, Anderson AC, Wölber JP, Ratka-Krüger P, Fretwurst T, Nelson K, Vach K, Hellwig E.

J Med Microbiol. 2018 Mar;67(3):332-340. doi: 10.1099/jmm.0.000682. Epub 2018 Jan 24.

PMID:
29458668
19.

Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.

Sabatos-Peyton CA, Nevin J, Brock A, Venable JD, Tan DJ, Kassam N, Xu F, Taraszka J, Wesemann L, Pertel T, Acharya N, Klapholz M, Etminan Y, Jiang X, Huang YH, Blumberg RS, Kuchroo VK, Anderson AC.

Oncoimmunology. 2017 Nov 9;7(2):e1385690. doi: 10.1080/2162402X.2017.1385690. eCollection 2018.

20.

A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.

Singer M, Wang C, Cong L, Marjanovic ND, Kowalczyk MS, Zhang H, Nyman J, Sakuishi K, Kurtulus S, Gennert D, Xia J, Kwon JYH, Nevin J, Herbst RH, Yanai I, Rozenblatt-Rosen O, Kuchroo VK, Regev A, Anderson AC.

Cell. 2017 Nov 16;171(5):1221-1223. doi: 10.1016/j.cell.2017.11.006. No abstract available.

21.

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, Borg C, Dalle S, Beatrix O, Ayyoub M, Balme B, Tomasic G, Di Giacomo AM, Maio M, Schadendorf D, Melero I, Dréno B, Khammari A, Dummer R, Levesque M, Koguchi Y, Fong L, Lotem M, Baniyash M, Schmidt H, Svane IM, Kroemer G, Marabelle A, Michiels S, Cavalcanti A, Smyth MJ, Weber JS, Eggermont AM, Zitvogel L.

Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2.

22.

The Effect of Nebulizer Position on Aerosolized Epoprostenol Delivery in an Adult Lung Model.

Anderson AC, Dubosky MN, Fiorino KA, Quintana V, Kaplan CA, Vines DL.

Respir Care. 2017 Nov;62(11):1387-1395. doi: 10.4187/respcare.05344. Epub 2017 Jul 18.

23.

Molecular Dissection of CD8+ T-Cell Dysfunction.

Wang C, Singer M, Anderson AC.

Trends Immunol. 2017 Aug;38(8):567-576. doi: 10.1016/j.it.2017.05.008. Epub 2017 Jun 26. Review.

24.

Antibiotic Resistance Genes and Antibiotic Susceptibility of Oral Enterococcus faecalis Isolates Compared to Isolates from Hospitalized Patients and Food.

Anderson AC, Andisha H, Hellwig E, Jonas D, Vach K, Al-Ahmad A.

Adv Exp Med Biol. 2018;1057:47-62. doi: 10.1007/5584_2017_53.

PMID:
28601926
25.

Pharmaceutical analysis of a novel propargyl-linked antifolate antibiotic in the mouse.

Hoody J, Alverson JB, Keshipeddy S, Barney PA, Walker L, Anderson AC, Wright DL, Priestley ND.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Apr 15;1051:54-59. doi: 10.1016/j.jchromb.2017.02.026. Epub 2017 Mar 6.

26.

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.

Dougall WC, Kurtulus S, Smyth MJ, Anderson AC.

Immunol Rev. 2017 Mar;276(1):112-120. doi: 10.1111/imr.12518. Review.

PMID:
28258695
27.

Direct Substitution of Arylalkynyl Carbinols Provides Access to Diverse Terminal Acetylene Building Blocks.

G-Dayanandan N, Scocchera EW, Keshipeddy S, Jones HF, Anderson AC, Wright DL.

Org Lett. 2017 Jan 6;19(1):142-145. doi: 10.1021/acs.orglett.6b03438. Epub 2016 Dec 13.

28.

MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates.

Reeve SM, Scocchera EW, G-Dayanadan N, Keshipeddy S, Krucinska J, Hajian B, Ferreira J, Nailor M, Aeschlimann J, Wright DL, Anderson AC.

Cell Chem Biol. 2016 Dec 22;23(12):1458-1467. doi: 10.1016/j.chembiol.2016.11.007. Epub 2016 Dec 8.

29.

OSPREY Predicts Resistance Mutations Using Positive and Negative Computational Protein Design.

Ojewole A, Lowegard A, Gainza P, Reeve SM, Georgiev I, Anderson AC, Donald BR.

Methods Mol Biol. 2017;1529:291-306.

30.

Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.

Li J, Falcone ER, Holstein SA, Anderson AC, Wright DL, Wiemer AJ.

Pharmacol Res. 2016 Nov;113(Pt A):438-448. doi: 10.1016/j.phrs.2016.09.020. Epub 2016 Sep 20.

31.

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.

Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF Jr.

Autoimmunity. 2016 Nov;49(7):472-479. Epub 2016 Aug 11.

32.

Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.

Lombardo MN, G-Dayanandan N, Wright DL, Anderson AC.

ACS Infect Dis. 2016 Feb 12;2(2):149-56. doi: 10.1021/acsinfecdis.5b00129. Epub 2016 Jan 4.

33.

A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.

Singer M, Wang C, Cong L, Marjanovic ND, Kowalczyk MS, Zhang H, Nyman J, Sakuishi K, Kurtulus S, Gennert D, Xia J, Kwon JYH, Nevin J, Herbst RH, Yanai I, Rozenblatt-Rosen O, Kuchroo VK, Regev A, Anderson AC.

Cell. 2016 Sep 8;166(6):1500-1511.e9. doi: 10.1016/j.cell.2016.08.052. Erratum in: Cell. 2017 Nov 16;171(5):1221-1223.

34.

Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.

Hajian B, Scocchera E, Keshipeddy S, G-Dayanandan N, Shoen C, Krucinska J, Reeve S, Cynamon M, Anderson AC, Wright DL.

PLoS One. 2016 Aug 31;11(8):e0161740. doi: 10.1371/journal.pone.0161740. eCollection 2016.

35.

Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens.

Scocchera E, Reeve SM, Keshipeddy S, Lombardo MN, Hajian B, Sochia AE, Alverson JB, Priestley ND, Anderson AC, Wright DL.

ACS Med Chem Lett. 2016 May 5;7(7):692-6. doi: 10.1021/acsmedchemlett.6b00120. eCollection 2016 Jul 14.

36.

Adolescent Narcissism, Aggression, and Prosocial Behavior: The Relevance of Socially Desirable Responding.

Barry CT, Lui JH, Anderson AC.

J Pers Assess. 2017 Jan-Feb;99(1):46-55. doi: 10.1080/00223891.2016.1193812. Epub 2016 Jun 30.

PMID:
27362301
37.

Antibacterial Antifolates: From Development through Resistance to the Next Generation.

Estrada A, Wright DL, Anderson AC.

Cold Spring Harb Perspect Med. 2016 Aug 1;6(8). pii: a028324. doi: 10.1101/cshperspect.a028324. Review.

38.

Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations.

Reeve SM, Scocchera E, Ferreira JJ, G-Dayanandan N, Keshipeddy S, Wright DL, Anderson AC.

J Med Chem. 2016 Jul 14;59(13):6493-500. doi: 10.1021/acs.jmedchem.6b00688. Epub 2016 Jun 28.

39.

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Anderson AC, Joller N, Kuchroo VK.

Immunity. 2016 May 17;44(5):989-1004. doi: 10.1016/j.immuni.2016.05.001. Review.

40.

Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS.

Nature. 2016 Aug 18;536(7616):359. doi: 10.1038/nature17421. Epub 2016 Mar 16. No abstract available.

41.

TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.

Jayaraman P, Jacques MK, Zhu C, Steblenko KM, Stowell BL, Madi A, Anderson AC, Kuchroo VK, Behar SM.

PLoS Pathog. 2016 Mar 11;12(3):e1005490. doi: 10.1371/journal.ppat.1005490. eCollection 2016 Mar.

42.

Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies.

Anderson AC, Mackey TK, Attaran A, Liang BA.

J Health Commun. 2016;21(4):397-407. doi: 10.1080/10810730.2015.1095816. Epub 2016 Feb 4. Review.

PMID:
26846423
43.

Natural Antimicrobials and Oral Microorganisms: A Systematic Review on Herbal Interventions for the Eradication of Multispecies Oral Biofilms.

Karygianni L, Al-Ahmad A, Argyropoulou A, Hellwig E, Anderson AC, Skaltsounis AL.

Front Microbiol. 2016 Jan 14;6:1529. doi: 10.3389/fmicb.2015.01529. eCollection 2015. Review.

44.

Enterococcus faecalis from Food, Clinical Specimens, and Oral Sites: Prevalence of Virulence Factors in Association with Biofilm Formation.

Anderson AC, Jonas D, Huber I, Karygianni L, Wölber J, Hellwig E, Arweiler N, Vach K, Wittmer A, Al-Ahmad A.

Front Microbiol. 2016 Jan 11;6:1534. doi: 10.3389/fmicb.2015.01534. eCollection 2015.

45.

The challenge of resistance in antimicrobial drug development.

Anderson AC, Wright DL.

Future Microbiol. 2015;10(11):1709-10. doi: 10.2217/fmb.15.75. No abstract available.

46.

The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.

Ignatius Arokia Doss PM, Roy AP, Wang A, Anderson AC, Rangachari M.

Front Immunol. 2015 Oct 22;6:541. doi: 10.3389/fimmu.2015.00541. eCollection 2015. Review.

47.

Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.

Reeve SM, Lombardo MN, Anderson AC.

Future Microbiol. 2015;10(11):1727-33. doi: 10.2217/fmb.15.78. Epub 2015 Oct 30. Review.

48.

TIGIT predominantly regulates the immune response via regulatory T cells.

Kurtulus S, Sakuishi K, Ngiow SF, Joller N, Tan DJ, Teng MW, Smyth MJ, Kuchroo VK, Anderson AC.

J Clin Invest. 2015 Nov 2;125(11):4053-62. doi: 10.1172/JCI81187. Epub 2015 Sep 28.

49.

Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) Alters In Situ Oral Biofilms.

Al-Ahmad A, Bucher M, Anderson AC, Tennert C, Hellwig E, Wittmer A, Vach K, Karygianni L.

PLoS One. 2015 Jul 10;10(7):e0132107. doi: 10.1371/journal.pone.0132107. eCollection 2015.

50.

Corrigendum: An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction.

Zhu C, Sakuishi K, Xiao S, Sun Z, Zaghouani S, Gu G, Wang C, Tan DJ, Wu C, Rangachari M, Pertel T, Jin HT, Ahmed R, Anderson AC, Kuchroo VK.

Nat Commun. 2015 Jul 8;6:7657. doi: 10.1038/ncomms8657. No abstract available.

PMID:
26153760

Supplemental Content

Loading ...
Support Center